National comorbidity survey replication adolescent supplement (NCS-A): I. Background and measures.
about
Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A)National comorbidity survey replication adolescent supplement (NCS-A): III. Concordance of DSM-IV/CIDI diagnoses with clinical reassessmentsEmotion regulation difficulties, youth-adult relationships, and suicide attempts among high school students in underserved communities.Diagnosis of depression in adolescents following traumatic fracture: a retrospective analysis.Longitudinal Assessment of Manic Symptoms (LAMS) study: background, design, and initial screening results.The Philadelphia Neurodevelopmental Cohort: constructing a deep phenotyping collaborativeThe saving and empowering young lives in Europe (SEYLE) randomized controlled trial (RCT): methodological issues and participant characteristics.School mental health services: signpost for out-of-school service utilization in adolescents with mental disorders? A nationally representative United States cohort.A zero- and K-inflated mixture model for health questionnaire data.Threshold and subthreshold generalized anxiety disorder among US adolescents: prevalence, sociodemographic, and clinical characteristicsThe effects of temporally secondary co-morbid mental disorders on the associations of DSM-IV ADHD with adverse outcomes in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A).Crime and psychiatric disorders among youth in the US population: an analysis of the National Comorbidity Survey-Adolescent SupplementAttention deficit hyperactivity disorder: concordance of the adolescent version of the Composite International Diagnostic Interview Version 3.0 (CIDI) with the K-SADS in the US National Comorbidity Survey Replication Adolescent (NCS-A) supplement.Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES.Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A).Prevalence and correlates of eating disorders in adolescents. Results from the national comorbidity survey replication adolescent supplement.Shyness versus social phobia in US youthEstimating population treatment effects from a survey subsample.Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement.Lifetime co-morbidity of DSM-IV disorders in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A).Eating disorder not otherwise specified presentation in the US population.Assessing eating disorder symptoms in adolescence: is there a role for multiple informants?Neighborhood sociodemographic predictors of Serious Emotional Disturbance (SED) in schools: demonstrating a small area estimation method in the National Comorbidity Survey (NCS-A) Adolescent SupplementThe psychosis spectrum in a young U.S. community sample: findings from the Philadelphia Neurodevelopmental CohortMajor depression in the national comorbidity survey-adolescent supplement: prevalence, correlates, and treatment.Using a short screening scale for small-area estimation of mental illness prevalence for schools.Health correlates of insomnia symptoms and comorbid mental disorders in a nationally representative sample of US adolescentsThe space of common psychiatric disorders in adolescents: comorbidity structure and individual latent liabilities.Ethnic and gender disparities in needed adolescent mental health care.Recovery from PTSD following Hurricane Katrina.Social phobia and subtypes in the national comorbidity survey-adolescent supplement: prevalence, correlates, and comorbidity.Comorbidity of physical and mental disorders in the neurodevelopmental genomics cohort study.Parent-child agreement in the reporting of headaches in a national sample of adolescentsEmpirically derived subtypes of lifetime anxiety disorders: developmental and clinical correlates in U.S. adolescents.Thresholds and accuracy in screening tools for early detection of psychopathology.Beyond Symptom Counts for Diagnosing Oppositional Defiant Disorder and Conduct Disorder?Validation of diagnoses of distress disorders in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A)Validation of the diagnoses of panic disorder and phobic disorders in the US National Comorbidity Survey Replication Adolescent (NCS-A) supplement.Structure of major depressive disorder in adolescents and adults in the US general populationChronology of Onset of Mental Disorders and Physical Diseases in Mental-Physical Comorbidity - A National Representative Survey of Adolescents.
P2860
Q28111792-C2DF4A5C-AC6E-419C-8738-CCC8B942E381Q28236815-62D5E5A3-C229-414A-B3FA-5AA3B52CA7DAQ30412843-EEFA8216-6FC6-4DD8-9C32-870D36C5E6A3Q30422023-45D70AFD-8F3D-407E-8A6D-E5A5920F966BQ30498409-FF989091-856A-45D9-ADE8-DF14606F3AC1Q30667231-35FEF87B-B620-4A68-B3D5-09A25C5A9BD1Q31117491-78370198-49A7-42FB-BB3F-47E06D78AEF9Q33728601-04BC17F9-1F30-4E9B-A7FE-21365CE4D3DCQ33834443-CE63AC58-9254-45A4-84A5-653EAE7209E8Q33838692-FFE214D8-BD5F-4FE9-B8CD-257181D1DB19Q34014855-EF11318D-B911-4D2A-BC57-4623366125FEQ34064175-9C6C1644-39EF-48BA-B7B7-BFDA2FC0F3FFQ34124735-C6924C7A-5244-42F5-A8F6-CF74FC1C39EAQ34124745-D2743EED-723A-4598-92E8-AD6EF2E4512BQ34154840-5B40558B-7B21-4EEA-A8F8-530B122EABECQ34169119-B6753F35-7153-429F-8542-69375000906BQ34225137-F4DCBE78-78C5-43BF-9DBB-58491F526A2FQ34230241-620BEB93-6172-46C0-98D8-D1F7A605F825Q34238905-74AB8D68-4AB8-40F4-9563-610629F1D43CQ34249387-A2111166-3E8B-4E67-8F94-5DD71FB2351BQ34260477-9656BA19-04E6-4A8A-BCBD-72A321D89EAEQ34281370-077A70F2-9FCA-418C-AD85-98F66DBD95E3Q34362628-F1B1BA3C-C1E9-4799-B609-40473829FEAAQ34447112-53671392-0D5B-4DC9-9A59-8D86BE5B3936Q34454744-ACF8ACA9-8B3F-4CA4-A386-5FB0EB7AF893Q34610727-0814C51B-C8F3-4495-AC11-AD0D3609AAFBQ34887515-B6B0D3F0-A85C-46E0-8519-8437E0FB2A14Q34987287-0689FA0A-69D5-4D56-A69F-F55794FAB57BQ35097473-74AC3A40-E722-4687-8E05-3B11C4FF823AQ35111166-5130923E-DAD8-4272-8659-B893A129F6FCQ35188830-D99D5DCF-CE28-4C02-8B02-B72680172F4AQ35232511-3077512C-E606-43F5-A2A2-DF0080E65FA4Q35644709-E3CC4310-EBAE-4921-A4A5-D8509EF1AB11Q35693407-683EB6BB-A44C-428D-B603-D96539B21925Q35941003-217A2DE1-6CF4-4E02-A952-24CA2FF3B8EDQ36032883-18B606EC-FB45-4E74-8608-0149F6CD58F9Q36108421-33918C0F-461B-47FC-B3CD-A8A82E1EE318Q36108425-C3077CEB-A33E-454E-BFC1-373F3E5B9311Q36131494-31EB4405-3CEC-4C05-AD3C-42FD12A73E67Q36170884-BDC58E0A-6A3F-4648-9845-B70E38ADAD6D
P2860
National comorbidity survey replication adolescent supplement (NCS-A): I. Background and measures.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
National comorbidity survey re ...... ): I. Background and measures.
@en
National comorbidity survey replication adolescent supplement
@nl
type
label
National comorbidity survey re ...... ): I. Background and measures.
@en
National comorbidity survey replication adolescent supplement
@nl
prefLabel
National comorbidity survey re ...... ): I. Background and measures.
@en
National comorbidity survey replication adolescent supplement
@nl
P2093
P2860
P1476
National comorbidity survey re ...... ): I. Background and measures.
@en
P2093
Doreen Koretz
Jane Costello
Kathleen Merikangas
Shelli Avenevoli
P2860
P304
P356
10.1097/CHI.0B013E31819996F1
P577
2009-04-01T00:00:00Z